SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-134343
Filing Date
2016-11-14
Accepted
2016-11-14 17:21:35
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v452444_10q.htm 10-Q 364996
2 EXHIBIT 10.01 v452444_ex10-01.htm EX-10.01 31369
3 EXHIBIT 31.1 v452444_ex31-1.htm EX-31.1 10261
4 EXHIBIT 31.2 v452444_ex31-2.htm EX-31.2 10559
5 EXHIBIT 32.1 v452444_ex32-1.htm EX-32.1 4136
6 EXHIBIT 32.2 v452444_ex32-2.htm EX-32.2 3987
  Complete submission text file 0001144204-16-134343.txt   2352310

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT svon-20160930.xml EX-101.INS 358810
8 XBRL TAXONOMY EXTENSION SCHEMA svon-20160930.xsd EX-101.SCH 28093
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svon-20160930_cal.xml EX-101.CAL 28755
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svon-20160930_def.xml EX-101.DEF 170171
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE svon-20160930_lab.xml EX-101.LAB 232678
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svon-20160930_pre.xml EX-101.PRE 196299
Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (908) 864-4444
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 161995959
SIC: 8731 Services-Commercial Physical & Biological Research